AKT1 and breast cancer: 20 μM UA inhibited the activity of AKT that resulted in decreased levels of key glycolytic enzymes, such as hexokinase (HK2) and pyruvate kinase (PKM2), and subsequently caused a decrease in ATP and lactate pools in breast cancer cells.